Two Mass. biotech startups undergo restructuring as industry funding wanes


Two Boston biotechs have implemented restructuring plans, one to extend cash runway and the other to change its geographic focus.

Previous Cincinnati Children’s to build new $42M research pavilion in Avondale
Next C-Suite Awards 2023: Michael Paduano, chief financial officer of Medicaid at UnitedHealthcare